This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Discover reliable places to access index level fundamentals and tips for evaluating the credibility and timeliness of the data you use.
17,495 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A wave of previously inaccessible BTC could re-enter markets in March, testing a fragile price zone and highlighting ...
Regulators in the UK are moving to dissolve a crypto exchange accused of aiding sanctions evasion. This article break...
Centuri Holdings ends 2025 with a booming backlog and falling debt, yet investors face a high bar to justify lofty va...
Gold back under $5,000 has traders weighing the next ETF move. This report compares key gold ETFs, costs, and what co...
Gas prices have moved sharply, with a $0.48 jump in one week. This article breaks down the reasons behind the move, w...
Robotaxi chatter tends to focus on all-or-nothing automation. This article explains why Uber's hybrid network could b...
The latest inflation report out shows retirees still face rising essentials even as COLA gains ease. Here's what that...
Elon Musk unveiled plans for a sprawling Terafab chip plant in Austin, promising ambitious production goals and thous...
A sweeping regulatory update defines most cryptocurrencies as commodities or digital tools, sparking a rally in crypt...
As energy demand grows, NuScale Power offers a potential long-term angle with small modular reactors. This guide expl...
Ethereum sits around $2,170 as the scaling debate intensifies. Analysts warn that a fragmented L2 path and security c...